// App-Quantinova.ai

: Impact of treprostinil on dynamin-related protein 1 (DRP1) and mitochondrial fragmentation in pulmonary arterial hypertension (PAH).

Researchers

Presenter

  • Jeries Abu-Hanna

Principal Investigators

  • Jan-Willem Taanman

  • David Abraham

  • Lucie Clapp

Medical Centers

  • Institute of Cardiovascular Science, University College London, London, United Kingdom

  • Institute of Neurology, University College London, London, United Kingdom

  • Division of Medicine, University College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • Cyclic AMP-dependent protein kinase

  • Utrophin

Drug/Treatment

  • Treprostinil

  • PF-04418948

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved